Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling
ML Shehata, D Lossnitzer, J Skrok… - American Journal of …, 2011 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this study was to assess predictors of MRI-identified septal
delayed enhancement mass at the right ventricular (RV) insertion sites in relation to RV …
delayed enhancement mass at the right ventricular (RV) insertion sites in relation to RV …
Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary …
Objective. Pulmonary arterial hypertension (PAH) is a life-threatening complication of
connective tissue diseases (CTD). Our aim was to compare the diagnostic utility of …
connective tissue diseases (CTD). Our aim was to compare the diagnostic utility of …
Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension
D Hagger, R Condliffe, N Woodhouse, CA Elliot… - …, 2009 - academic.oup.com
Objective. The ventricular mass index (VMI) has been proposed as a diagnostic tool for the
assessment of patients with suspected pulmonary hypertension (PH). We hypothesized that …
assessment of patients with suspected pulmonary hypertension (PH). We hypothesized that …
High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX …
R Bergemann, J Allsopp, H Jenner… - Pulmonary …, 2018 - journals.sagepub.com
Idiopathic pulmonary arterial hypertension (iPAH) is a rare progressive, life-shortening
disease, usually diagnosed at an advanced stage. We hypothesize that patients with iPAH …
disease, usually diagnosed at an advanced stage. We hypothesize that patients with iPAH …
[PDF][PDF] Bibliometric and visual analysis of hypoxic pulmonary hypertension from 2013 to 2022
W Yang, J Shen, G Shi, T Zhang, W Wei, C Wang… - Heliyon, 2023 - cell.com
Hypoxic pulmonary hypertension (HPH) is caused by chronic persistent hypoxia, which
leads to the continuous increase of pulmonary artery pressure and pulmonary vascular …
leads to the continuous increase of pulmonary artery pressure and pulmonary vascular …
[HTML][HTML] Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in World Health Organisation functional class I
CG Billings, R Lewis, IJ Armstrong, JA Hurdman… - Frontiers in …, 2018 - frontiersin.org
Background: There is increasing interest in screening for and diagnosing pulmonary
hypertension earlier in the course of disease. However, there is limited data on …
hypertension earlier in the course of disease. However, there is limited data on …
Imaging in pulmonary hypertension: the role of MR and CT
S Rajaram - 2013 - etheses.whiterose.ac.uk
Pulmonary hypertension (PH) is a debilitating disease with many causes that has a
significant impact on quality of life and results in premature death. Until recently imaging has …
significant impact on quality of life and results in premature death. Until recently imaging has …
[BOOK][B] Beet-ing Muscle Dysfunction and Exercise Intolerance in Pulmonary Hypertension
GM Long - 2019 - search.proquest.com
Background: Pulmonary Hypertension (PH) is a devastating disease characterized by
pulmonary arterial remodeling, right ventricular dysfunction and ultimately right heart failure …
pulmonary arterial remodeling, right ventricular dysfunction and ultimately right heart failure …
Opterećenje desnog srca u plućnoj hipertenziji
S Paradžik - 2021 - repozitorij.mef.unizg.hr
Sažetak Plućna hipertenzija je definirana srednjim plućnim arterijskim tlakom (mPAP)≥
25mmHg. Zahvaća približno 1% odrasle populacije. Prema Svjetskoj zdravstvenoj …
25mmHg. Zahvaća približno 1% odrasle populacije. Prema Svjetskoj zdravstvenoj …
Influences of first-line oral monotherapy on outcomes in Pulmonary Arterial Hypertension in association with Connective Tissue Disease.
ND Hamilton - 2015 - bradscholars.brad.ac.uk
Background Pulmonary arterial hypertension (PAH) is a rare progressive disease with no
known cure. Of various aetiologies, PAH in association with connective tissue disease (PAH …
known cure. Of various aetiologies, PAH in association with connective tissue disease (PAH …